Vaccine vial of H5N1 in a bottle with a syringe on a blue background. There are several licensed vaccines for avian influenza in poultry, but their use has not been authorized in the U.S. during ...
Shares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned ...
Stock photo of a syringe. Experts are urging the Biden administration to approve a vaccine for the H5N1 bird flu virus. Stock photo of a syringe. Experts are urging the Biden administration to ...
Moderna continues to cut costs, which could raise questions about the vaccine playbook used during the Covid-19 pandemic.
Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...
Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.
Kennedy. A known vaccine skeptic, Kennedy questioned the need for a human bird flu vaccine on X last July. A vaccine for animals may be more politically palatable for the new Trump administration.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of new vaccines, including an mRNA shot. On Friday, the Department of Health ...
There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...
Although a candidate bird flu vaccine has not yet been made commercially available, medical experts advise that people should get it once it is. Dr. Linda Yancey, an expert in infectious ...
The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.